文献速递外周动脉疾病主动脉疾病

现代背景下主双股动脉旁路术的手术复杂性与既往腔内干预对术后并发症的负面影响

Operative Complexity and Prior Endovascular Intervention Negatively Impact Morbidity after Aortobifemoral Bypass in the Modern Era.
PubMed 文献 · Ann Vasc Surg · 2019-06-13

本研究回顾性分析了2000至2017年256例初次主双股动脉旁路术(ABF)患者,发现30天死亡率为2.7%,主要并发症发生率为35.9%。既往腔内干预、恶性肿瘤、术中并发症、手术出血量和主动脉补片内膜剥脱术是主要并发症的预测因素,而远期生存受恶性肿瘤、合并症、肢体缺血程度和出血量影响。

要点

  • 既往主髂动脉腔内干预使ABF术后主要并发症风险增加(OR 2.2)。
  • 手术复杂性(如补片内膜剥脱术、出血量)与并发症风险独立相关。
  • 远期生存主要由肢体缺血程度和合并症驱动,而非手术复杂性。

核心结论

  • 现代ABF术后远期结果尚可,但主要并发症常见。
  • 手术复杂性和既往腔内血运重建可预测并发症。
  • 远期生存由肢体缺血程度和合并症驱动。

研究设计与样本

  • 回顾性队列研究,纳入2000至2017年接受初次ABF的患者256例。
  • 平均年龄67.9±10.6岁,女性占51.2%。
  • 采用逻辑回归和Cox比例风险模型分析预测因素。

主要发现

  • 30天死亡率为2.7%,主要并发症发生率为35.9%。
  • 主要并发症预测因素包括既往腔内干预(OR 2.2,95%CI 1.2-4.1,P=0.01)、恶性肿瘤(OR 2.6,95%CI 1.3-5.3,P=0.01)、术中并发症(OR 3.3,95%CI 1.3-9.2,P=0.03)、手术出血量(每100ml OR 1.0,95%CI 1.0-1.0,P=0.03)和补片内膜剥脱术(OR 1.8,95%CI 1.0-3.1,P=0.04)。
  • 中位随访5.3年(四分位距7.2年),1、3、5年生存率分别为94%、90%、82%。
  • 5年主要通畅率和免于再干预率分别为76%和79%。
  • 晚期死亡预测因素包括恶性肿瘤(HR 2.3,95%CI 1.3-3.9,P<0.01)、慢性阻塞性肺疾病(HR 1.8,95%CI 1.1-3.1,P=0.02)、充血性心力衰竭(HR 2.3,95%CI 1.2-4.3,P=0.01)、Rutherford分级(HR 1.5,95%CI 1.1-2.1,P=0.01)、手术出血量(每100ml HR 1.0,95%CI 1.0-1.0,P=0.04)和慢性肾脏病(HR 2.3,95%CI 1.2-4.2,P=0.01)。

临床怎么用

  • 在选择ABF患者时,应评估既往腔内干预史和手术复杂性,以优化患者选择。
  • 对于合并恶性肿瘤、心力衰竭、慢性肾脏病等患者,需权衡ABF的风险与获益。

局限性

  • 回顾性研究设计可能存在选择偏倚。
  • 单中心数据可能限制结果的普遍性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovascular therapy is first-line treatment for aortoiliac occlusive disease. This shift has altered case volume, patient selection, and risk profile for aortobifemoral bypass (ABF). Given this, we sought to investigate factors influencing morbidity and mortality after ABF in the endovascular era. METHODS: Data for patients undergoing primary ABF from 2000 to 2017 were queried. Primary endpoints included major complication (unplanned return to the operating room, life-or-limb-threatening complications, and 30-day readmission or death) and long-term survival. Logistic regression and Cox proportional hazard models determined predictors of primary endpoints. Kaplan-Meier analysis estimated patency, freedom from reintervention, and long-term survival. RESULTS: During these 17 years, 256 patients underwent primary ABF. Mean age was 67.9 ± 10.6 years and 51.2% were women. Most had claudication (69.5%); 28.9% had critical ischemia. Sixty-five (25.4%) patients had prior aortoiliac endovascular intervention, 106 (41.4%) required aortic cuff endarterectomy, 111 (43.3%) femoral outflow adjunct, 9 (3.5%) simultaneous lower extremity bypass, and 230 (89.8%) had Trans-Atlantic Inter-Society Consensus D lesions. Concomitant renovisceral revascularization was needed in 42 (16.4%) patients. Thirty-day mortality was 2.7%. Major complication occurred in 92 patients (35.9%). Predictors included prior endovascular intervention (odds ratio [OR], 2.2; 95% confidence interval [CI]: 1.2-4.1; P = 0.01), malignancy (OR, 2.6; 95% CI: 1.3-5.3; P = 0.01), intraoperative complication (OR, 3.3; 95% CI: 1.3-9.2; P = 0.03), operative blood loss, (OR, 1.0 per 100 ml; 95% CI: 1.0-1.0; P = 0.03), and cuff endarterectomy (OR, 1.8; 95% CI: 1.0-3.1; P = 0.04). Median follow-up was 5.3 years (interquartile range: 7.2 years). Survival at 1, 3, and 5 years was 94%, 90%, and 82% respectively. Primary patency and freedom from reintervention at 5 years were 76% and 79%, respectively. Predictors of late mortality included malignancy (hazard ratio [HR], 2.3; 95% CI: 1.3-3.9; P < 0.01), chronic obstructive pulmonary disease (HR, 1.8; 95% CI: 1.1-3.1; P = 0.02), congestive heart failure (HR, 2.3; 95% CI: 1.2-4.3; P = 0.01), Rutherford's class (HR, 1.5; 95% CI: 1.1-2.1; P = 0.01), operative blood loss (HR 1.0 per 100 ml; 95% CI: 1.0-1.0; P = 0.04) and chronic kidney disease (HR, 2.3; 95% CI: 1.2-4.2; P = 0.01). CONCLUSIONS: Although late outcomes after ABF in the contemporary era remain acceptable, major complications are frequent. Operative complexity and prior endovascular revascularization predict complications. Long-term survival is driven by degree of limb ischemia and comorbidities. These should be considered in selection for ABF, potentially modifying approach to improve outcomes.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. DeCarlo C, Boitano LT, Schwartz SI, et al. Operative Complexity and Prior Endovascular Intervention Negatively Impact Morbidity after Aortobifemoral Bypass in the Modern Era. Ann Vasc Surg. 2019. PMID: 31201980. doi:10.1016/j.avsg.2019.03.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。